Delcath Systems (OTC: DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. The company’s proprietary product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The company has commenced a global phase 3 FOCUS clinical trial for patients with hepatic dominant ocular melanoma and plan to initiate a registration trial for intrahepatic cholangiocarcinoma (“ICC”) in the fall of 2017. The company’s Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (“CHEMOSAT”) has been commercially available in Europe since 2012. For more information, visit the company’s website at www.delcath.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
